Expression of the cloned lysostaphin gene

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4931390
SERIAL NO

07034464

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides recombinant plasmids which is transformant microbial hosts express lysostaphin, a bacteriocin that kills most known staphylococcal species. The invention also provides lysostaphin, substantially free from non-lysostaphin contaminants. Recombinant plasmids, pRG5, pJP1, pDF8 and pRP1, were derived by inserting a 1.5 kilobase segment of DNA coding for lysostaphin into the cloning vectors, pUC8, pBC16, pBD64 and pSPV1, respectively. E. coli strain JM105 transformed by pRG5 and members of Bacillus species, including B. subtilis and B. sphaericus transformed by pJP1, pDF8 and pRP1 produce lysostaphin which is immunologically and electrophoretically indistinguishable from that produced by S. simulans, the natural source. Furthermore, B. sphaericus strain 00/pJP1 transformants produce five times the amount of lysostaphin as S. simulans. The invention also provides the 1.5 kbp DNA fragment coding for lysostaphin. The sequence of the DNA encodes preprolysostaphin, a monomeric 389 amino acid protein, which is posttranslationally processed to mature lysostaphin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY335 GEORGE STREET SUITE 3200 NEW BRUNSWICK NJ 08901

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Recsei, Paul A New York, NY 2 33

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation